5 Breast Cancer Bloggers Share Their Stories in Woman’s Day

Woman's Day Magazine has asked me to participate in a story on breast cancer blogger. I hope you read the article and the four other blogs breast cancer that were included in the visit history.

It was really a great opportunity for me to reflect on the experience of blogging for some time to spend on breast cancer. God knows, I reflect the experience of breast cancer often have enoughC but thinking about blogging about it? Well, this is a little different twist.

In general, the writing of this blog has been really good for me. But occasionally, it has not come. And then I disappear for a while. So I am not normally consider myself a breast cancer Blogger law. Good bloggers do not disappear for a while. This is the kind of basic rule of blogging: in press.

Once, after such a long time without post, I wrote a post about the sad fact that sometimes to stop publishing for bloggers breast cancer tragic reasons.

But I think the breast cancer bloggers are probably willing to cut some loose. We understand that life is complicated and we have a duty to protect ourselves against stress, whenever possible.

One thing about my breast cancer blog, I'm proud of this: I have answered all the individual e-mail from a breast cancer survivor who came to me.

Mesothelioma treatment and research for the future use assessed

A new study in Current Medicinal Chemistry C. Belli and colleagues published analysis of angiogenic factors in cancer development of malignant mesothelioma.

Angiogenesis is the process of growth of new blood vessels from existing vessels. Researchers believe that a better understanding of the molecular mechanisms and pathways involved in angiogenesis, the basis for the development of new drugs against malignant mesothelioma. These drugs against these pathways may affect the proliferation and survival of tumor cells.

The standard treatment for patients with mesothelioma is chemotherapy with cisplatin and pemetrexed combination of drugs. However, the use of chemotherapy did not always have a significant impact on improving survival rate. The average life expectancy of mesothelioma varies between four and 18 months after diagnosis.

Mesothelioma is a cancer caused almost exclusively by asbestos. The main reason why most patients are diagnosed at an advanced stage of development is that the latency of severe symptoms. The symptoms often occur once the cancer has already developed, sometimes up to 50 years from the time that someone has been exposed to asbestos first.

The study examined the role of angiogenic factors in tumor development by reviewing the results of clinical studies, articles, abstracts and presentations of the American Society of Clinical Oncology. Information on clinical trials in ClinicalTrials.gov found.

According to the researchers activated the hope of a better understanding of the process of angiogenesis in malignant mesothelioma, to provide new therapeutic options for these patients in the future.